Mounjaros innovative dual-action mechanism provides broader weight loss and glycemic control compared to traditional GLP-1 medications
By utilizing fats for energy production, this supplement helps conserve glycogen and delay the buildup of lactic acid, which in turn reduces muscle fatigue and extends the horse's ability to perform at peak levels
PlexusDx helps identify your genetic profile to optimize your individual timeline
Currently, 70% of the GLP-1 market is in the US and partially the EU, with a staggering 300% growth from 2020 to 2023 in prescriptions within the US alone
The STEP 1 trial (Wilding et al., The Lancet, 2021) showed an average weight loss of 14.9% over 68 weeks versus 2.4% in the placebo group a landmark result that established semaglutide as the benchmark for GLP-1 weight loss
The decision to switch between the Wegovy injection and semaglutide pill is a personal one and will depend on several factors, including whether youd prefer a daily pill or a weekly injection